Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email


Check back regularly for news, coverage, and announcements about MAVA.


H.I.G. BioVentures Joins $15.5 Million Series A For Intact Vascular

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced the completion of a $15.5 MM Series A financing. The proceeds from this financing will be used to continue clinical studies of the Tack-It Endovascular Stapler System™, a novel endovascular stapling device designed to optimize peripheral angioplasty results for the treatment of peripheral artery disease (PAD). Leading healthcare investment firms Quaker Partners and H.I.G. BioVentures co-led the round in addition to participation from angel investors. With the close of the financing, Dennis Wahr, M.D., the former CEO of Lutonix (recently sold to C.R. Bard), has been appointed Chairman of the Board of Directors.

Read More